Genetic Susceptibility to Schizophrenia: Role of Dopaminergic Pathway Gene Polymorphisms
- 10 February 2009
- journal article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 10 (2) , 277-291
Abstract
We investigated 16 polymorphisms from three genes, dopamine receptor D2 (DRD2), catechol-O-methyl transferase (COMT) and brain derived neurotrophic factor (BDNF), which are involved in the dopaminergic pathways, and have been reported to be associated with susceptibility to schizophrenia and response to antipsychotic therapy. Single-locus association analyses of these polymorphisms were carried out in 254 patients with schizophrenia and 225 controls, all of southern Indian origin. Additionally, multifactor-dimensionality reduction analysis was performed in 422 samples (243 cases and 179 controls) to examine the gene-gene interactions and to identify combinations of multilocus genotypes associated with either high or low risk for the disease. Our results demonstrated initial significant associations of two SNPs for DRD2 (rs11608185, genotype: chi(2) = 6.29, p-value = 0.043; rs6275, genotype: chi(2) = 8.91, p-value = 0.011), and one SNP in the COMT gene (rs4680, genotype: chi(2) = 6.67, p-value = 0.035 and allele: chi(2) = 4.75, p-value = 0.029; odds ratio: 1.33, 95% confidence interval: 1.02-1.73), but not after correction for multiple comparisons indicating a weak association of individual markers of DRD2 and COMT with schizophrenia. Multifactor-dimensionality reduction analysis suggested a two locus model (rs6275/DRD2 and rs4680/COMT) as the best model for gene-gene interaction with 90% cross-validation consistency and 42.42% prediction error in predicting disease risk among schizophrenia patients. The present study thus emphasizes the need for multigene interaction studies in complex disorders such as schizophrenia and to understand response to drug treatment, which could lead to a targeted and more effective treatment.Keywords
Funding Information
- Department of Biotechnology
- Council of Scientific and Industrial Research
This publication has 72 references indexed in Scilit:
- No Significant Association of 14 Candidate Genes With Schizophrenia in a Large European Ancestry Sample: Implications for Psychiatric GeneticsAmerican Journal of Psychiatry, 2008
- Association of dopamine receptor polymorphisms with schizophrenia and antipsychotic response in a South Indian populationBehavioral and Brain Functions, 2007
- Association between the C957T polymorphism of the dopamine D2 receptor gene and schizophreniaNeuroscience Letters, 2006
- Pharmacogenomics: A Path to Predictive Medicine for SchizophreniaPharmacogenomics, 2005
- MLC1 Gene Is Associated with Schizophrenia and Bipolar Disorder in Southern IndiaBiological Psychiatry, 2005
- DRD2 −141C insertion/deletion polymorphism is not associated with schizophrenia: Results of a meta‐analysisAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2004
- Overview: Towards individualized treatment in schizophreniaDrug Development Research, 2003
- No association of the Ser/Cys311 DRD2 molecular variant with schizophrenia using a classical case control study and the haplotype relative riskSchizophrenia Research, 1997
- A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophreniaHuman Molecular Genetics, 1997
- Dopamine receptors and the dopamine hypothesis of schizophreniaSynapse, 1987